Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
NICE has issued technology appraisals supporting the use of semaglutide (Wegovy) and tirzepatide (Mounjaro) within defined clinical criteria for weight management, alongside structured lifestyle interventions
Limitations Our study had some limitations
We begin you on the lowest dosage and will gradually increase it to the target one to maximize your chances of the best outcome while minimizing your risk of side effects
Lost 14 pounds in 3 months
Common side effects include nausea, vomiting, diarrhea, constipation, and indigestion, particularly during the first few weeks of treatment
US$ 22.38
US$ 28.43
US$ 26.83
US$ 23.32
US$ 25.41
US$ 28.68
US$ 23.82
US$ 25.89
